Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Revenue
Total revenue	$ 5,722,379	$ 5,858,202
Operating Expenses and Costs
Practice salaries and benefits	3,231,117	3,335,695
Other practice operating expenses	2,205,085	2,566,191
Cost of product revenue	142,501	463,156
Selling, general and administrative expenses	3,623,402	4,577,490
Depreciation and amortization	352,027	829,481
Impairment loss	319,958	2,745,563
Total Operating Expenses and Costs	9,874,090	14,517,576
Loss from operations	(4,151,711)	(8,659,374)
Other Income (Expenses)
Loss on extinguishment of debt	(145,212)
Gain from expiration of liability classified equity instruments	92,641
Financing cost		(110,000)
Amortization of original issue discounts on notes payable	(427,808)	(55,282)
Gain from realization of contingent sale consideration receivable	1,090,857
Change in fair value of contingent acquisition consideration	11,094	779,999
Interest expense and other	(83,812)	(22,825)
Total other income (expenses)	537,760	591,892
Loss from continuing operations before provision for income taxes	(3,613,951)	(8,067,482)
Provision for income taxes
Loss from continuing operations	(3,613,951)	(8,067,482)
Discontinued operations (Note 4)
Loss from operations of discontinued operations	(72,321)	(748,262)
Gain from disposal of discontinued operations	2,674,069
Gain (loss) on discontinued operations	2,601,748	(748,262)
Net loss	(1,012,203)	(8,815,744)
Deemed dividend - amortization of beneficial conversion feature		(353,571)
Net loss to common shareholders	$ (1,012,203)	$ (9,169,315)
Loss per share from continuing operations, basic and diluted:
Basic (in Dollars per share)	$ (0.01)	$ (0.03)
Fully diluted (in Dollars per share)	(0.01)	(0.03)
Gain (loss) on discontinued operations, basic and diluted:
Basic (in Dollars per share)	0.01	0
Fully diluted (in Dollars per share)	0.01	0
Net loss per share to common shareholders, basic and diluted:
Basic (in Dollars per share)	0	(0.04)
Fully diluted (in Dollars per share)	$ 0	$ (0.04)
Weighted average number of common shares:
Basic (in Shares)	262,891,873	243,419,736
Fully diluted (in Shares)	262,891,873	243,419,736
Patient service revenue, net
Revenue
Total revenue	$ 5,484,278	$ 5,407,416
Subscription and event revenue
Revenue
Total revenue	58,901	20,835
Product revenue
Revenue
Total revenue	$ 179,200	$ 429,951